DBV Technologies (DBVT) Total Debt (2015 - 2019)
DBV Technologies (DBVT) reported Total Debt of $1.4 million for Q4 2019, down 49.22% year-over-year from $2.8 million in Q4 2018, and down 49.22% quarter-over-quarter from $2.8 million in Q4 2018.
DBV Technologies (DBVT) Total Debt (2015 - 2019) Analysis & Trends
DBV Technologies (DBVT) has 5 years of Total Debt data on file, last reported at $1.4 million in Q4 2019.
- Total Debt for Q4 2019 came in at $1.4 million, down 49.22% year-over-year; the trailing twelve-month figure through Dec 2019 was $1.4 million (down 49.22% YoY), and the FY2019 annual result was $1.4 million, down 49.22% from the prior year.
- Total Debt retreated to $1.4 million in Q4 2019 per DBVT's latest filing, from $2.8 million in the prior quarter.
- Over five years, Total Debt peaked at $5.3 million in Q4 2015 and troughed at $1.4 million in Q4 2019.
- A 5-year average of $3.9 million and a median of $4.9 million in 2017 frame the typical range for Total Debt.
- The sharpest annual moves came in 2017 and 2019: Total Debt slipped 2.47% in 2017, then slumped 49.22% in 2019.
- A 5-year view of Total Debt shows it stood at $5.3 million in 2015, then retreated by 5.6% to $5.0 million in 2016, then decreased by 2.47% to $4.9 million in 2017, then sank by 42.09% to $2.8 million in 2018, then tumbled by 49.22% to $1.4 million in 2019.
- Business Quant data shows DBVT's Total Debt at $1.4 million in Q4 2019, $2.8 million in Q4 2018, and $4.9 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1.44 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Dec 31, 2017 | 4.89 Mn |
| Dec 31, 2016 | 5.01 Mn |
| Dec 31, 2015 | 5.31 Mn |